BDNF and Cognitive impairment: Additionally, the pre-treatment with ANA12, a TrkB antagonist, has been reported to block BDNF signaling and exacerbate cognitive impairments [27], further suggesting the BDNF signaling through TrkB is closely linked to cognitive dysfunction.